Results 171 to 180 of about 45,555 (245)

Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 11, November 2026.
This review summarizes recent advances in combined pulmonary fibrosis and emphysema (CPFE), proposing a novel etiologic classification framework encompassing four subtypes. We integrate a diagnostic algorithm to guide precise management and highlight emerging artificial intelligence strategies for risk stratification and dynamic prognostic assessment ...
Qinyu Deng   +5 more
wiley   +1 more source

Radiotherapy for Cervical Cancer: Technical Advances, Clinical Applications, and Future Perspectives

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 11, November 2026.
ABSTRACT Radiotherapy is an essential treatment modality for cervical cancer and has evolved substantially with advances in image guidance and treatment delivery. This review summarizes recent technological developments in external beam radiotherapy and brachytherapy, their clinical applications, and future directions, with particular consideration of ...
Hitoshi Maemoto   +2 more
wiley   +1 more source

Evolving role of proton therapy in contemporary oncology

open access: yesCancer, Volume 132, Issue 20, 15 October 2026.
Abstract Proton therapy offers a distinct physical advantage over photon radiotherapy through the Bragg peak dose concentration in target with both lower integral dose and finite path length, and sharper penumbra as compared to photons, collectively reducing radiation exposure to surrounding normal tissues and potentially improving the therapeutic ...
Emily S. Lebow, Helen A. Shih
wiley   +1 more source

Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 1857-1872, 15 October 2026.
ABSTRACT Clinical trials combining radiotherapy (RT) with immune checkpoint blockade (ICB) have shown improved outcomes in only a fraction of patients, and optimal strategies for integrating these modalities remain under intense investigation. With a few exceptions, phase III combination trials have yielded disappointing results.
Xuanwei Zhang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy